POTENTIAL ВIOMARKERS OF ENDOMETRIOSIS: THE SEARCH IS UNDERWAY

ALIYA SH. ZARIPOVA, Р. И. Габидуллина, F. F. MINNULLINA, DINARA I. AKHMETOVA, Y.V. Orlov
In: The Bulletin of Contemporary Clinical Medicine · 2023 · vol. 16(6) , pp. 103–109 · doi:10.20969/vskm.2023.16(6).103-109 · W4389516262
Review OA: diamond CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This review summarizes contemporary literature on potential biomarkers for early endometriosis diagnosis, highlighting metabolomics, genomics, and proteomics as promising areas for multi-marker panels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract. Introduction. Endometriosis is a chronic estrogen-dependent disease characterized by the presence of endometrial-like tissue outside the uterine cavity and most often manifested by pelvic pain and infertility. It affects up to 10% of women of reproductive age, which is about 190 million women worldwide, and it is a serious medical and social issue. In the clinical context, it is advisable to search for biomarkers of the disease to ensure early noninvasive diagnosis. Current literature on potential biomarkers of endometriosis is already quite extensive. However, despite many publications, there is no consensus on and no similar approaches to defining such markers. Therefore, the search for potential biomarkers of endometriosis is still relevant. Aim: To summarize the information of contemporary literature on possible biomarkers of endometriosis that can be used in its early diagnosis and treatment. Materials and Methods. This is a review of publications based on search results in electronic resources in Russian and international systems, such as eLibrary, PubMed, MedLine, Crossref, etc., over the past 8 years (2015-2023). Results and Discussion. A constantly improving palette of the latest technologies that include and combine metabolomics, genomics, and proteomics, can be the key to success in finding reliable biomarkers. For such a complex and heterogeneous disease as endometriosis, a panel of biomarkers is likely to be more accurate than a single marker, both for the diagnosis and probably for helping classify subtypes of the disease. Conclusion. Current literature on potential biomarkers is quite extensive, but the desired result has not been achieved yet. Further research is needed.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (49)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK